"Breakthrough new drugs such as specialized oncology treatments as well as new applications for existing drugs — like GLP-1 ...
Merck's affordable Ebola vaccine initiatives, Abbott's profit challenges, U.S. vaccination policy changes under Health ...
Pharmaceutical Cliff Diving is a consultancy-style report which identifies, assesses, and provides insights on the key challenges that industry is experiencing now and in the near future. Through CBR ...
Pharmaceutical Technology on MSN
Walking the pharma supply chain tightrope requires more than precision
Staying ahead of pharma supply challenges rests on anticipatory pillars and does not require reinventing the wheel, says ...
Explore key identity management challenges in pharma and biotech SaaS platforms and learn practical solutions for security, ...
Pharma's investment in the digital health space is getting more and more real and substantive as companies move beyond the pilot stage and start to launch real digital health interventions, from Teva ...
Cantor Fitzgerald writes that the Skytrofa update probably overshadowed another key update from the call. Achieving breakeven this year is unlikely unless the company significantly reduces costs, ...
As more and more partnerships between digital therapeutics and pharma companies begin to emerge, the two industries have started to size each other up. While this may foster an exchange of ideas, ...
Functional packaging materials are increasingly designed to actively protect drug products, integrating moisture and impurity ...
A pharmaceutical company is currently appealing a record USD1.6 billion judgment in the US, arguing that a key part of the US False Claims Act (FCA) is unconstitutional. This case, now before the ...
POTOMAC, MD / ACCESS Newswire / January 28, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC Pharma" or the "Company") is proud to announce its selection as one of the top 15 finalists in the PREPARE ...
Tuesday, Ascendis Pharma A/S (NASDAQ:ASND) reported second-quarter sales of $38.76 million (35.9 million euros), missing the consensus of $92.7 million, down from 47.4 million euros reported a year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results